BRTX vs TYL · rev $401.0K vs P/E 89, rev $2.14B
BioRestorative Therapies Inc (BRTX) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported TYL revenue for 2024-12-31 was $2.14B. Net income was $263.0M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
BRTX currently screens at market cap $10.2M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the BRTX and TYL stock pages for the full models.
Not investment advice.